Classification: Dermatological Species: Dogs Want to make a note? You need to be logged in to perform this operation. LOG IN REGISTER Save productRemove product This product has been saved Check out all saved products in "Saved Content" VIEW NOW I GOT IT This product has been removed This product has been removed from your "Saved Content" I GOT IT Log in to save this content LOG IN REGISTER Indications and Contraindications Indications Indicated for the control of pruritus associated with allergic dermatitis and the control of atopic dermatitis in dogs. Contraindications/Precautions Should not be administered to dogs that are sensitive to the active ingredient Ilunocitinib and that are under 12 months of age. Adverse Effects Control of Atopic Dermatitis In a field study conducted with Zenrelia to evaluate the control of atopic dermatitis, adverse reactions were observed in a similar proportion in the placebo and treated groups. Serious adverse reactions were rare. Although a higher percentage of dogs in the Zenrelia-treated group had reduced white blood cell counts (eosinophils, neutrophils, and lymphocytes) and increased mean corpuscular hemoglobin (MCH) compared to placebo-treated dogs, group means for all hematologic variables remained within normal ranges. Control of Pruritus Associated with Allergic Dermatitis In a field study with Zenrelia to evaluate the control of pruritus associated with allergic dermatitis, adverse reactions were observed in a similar proportion in the placebo and treated groups. Serious adverse reactions were rare. Although a small number of Zenrelia-treated animals had reduced absolute reticulocyte and white blood cell counts, and elevated nucleated red blood cell counts, at various time points during the study, group means for all hematologic parameters remained within normal ranges at all time points. Among serum chemical parameters, mean triglycerides and cholesterol were slightly elevated in the Zenrelia-treated group compared to the placebo group. These changes were mild and did not result in any clinical signs. Reproduction, Pregnancy, and Lactation: The safety of Zenrelia has not been evaluated in breeding, pregnant, or lactating dogs.
